Legal status · Canada
Is TIMP2 legal in Canada?
Written by Aaron CuhaReviewed Sep 2026
Direct answer
No. TIMP2 is not an approved medicine in Canada; its classification is "Research use only; not approved". Nothing containing it is authorized for any use in people. Vials labeled "for research use only" are not exempt: that label does not make human use lawful. On the evidence, 1 human study is cited on its profile.
TIMP2 in Canada at a glance
| Classification | Research use only; not approved |
|---|---|
| Health Canada approval status | Not approved by Health Canada |
| Human studies cited | 1 of 4 citations on the profile |
| Reviewed | Sep 2026 |
Classification and note come from the TIMP2 profile, checked against Health Canada, Health Products and Food Branch (Health Canada) listings at the reviewed date.
What this means
- 01
No product containing TIMP2 is approved by Health Canada for any use in Canada, so nothing on the market is authorized for people.
- 02
"Research use only" is a vendor label, not a legal category that permits human use. It does not exempt a product from medicines law.
- 03
Importing, supplying or promoting it for human use can fall under medicines legislation in Canada. This page is general information, not legal advice.
What TIMP2 is
A protein enriched in human umbilical cord plasma that restored hippocampal plasticity and memory in aged mice. It is already measured in people, as an acute kidney injury biomarker, but has never been given to one.
TIMP2 is a naturally occurring inhibitor of matrix metalloproteinases, present in everyone's blood. It became a longevity target through a 2017 Nature paper which asked whether human umbilical cord plasma, the earliest developmental stage of plasma available, contains plasticity-promoting factors.
Mechanism: In mice, systemically administered TIMP2 enters the brain and increases hippocampal synaptic plasticity and hippocampal-dependent cognition, and it is necessary for the cognitive benefit of human cord plasma. Blocking it with an antibody prevents long-term potentiation in brain slices, and neuronal TIMP2 regulates the complexity of the extracellular matrix around hippocampal neurons.
Regulatory history: Not approved as a therapy anywhere and never administered to a human. TIMP-2, in combination with IGFBP7, is used as a clinical laboratory biomarker for risk of acute kidney injury, which is a diagnostic use and not a treatment.
How Health Canada treats this kind of product
Authorises drugs for sale through a Notice of Compliance and Drug Identification Number. A compound that is not authorised for sale cannot lawfully be sold for human use, and personal importation of prescription drugs is limited.
The classification above is the The Longevity Archive reading of Health Canada, Health Products and Food Branch listings for TIMP2 at the reviewed date, not a legal opinion. Rules change, and importing, prescribing and possessing a compound can each be treated differently. Check the regulator directly before acting on anything here.
TIMP2 in other countries
Frequently asked questions
Is TIMP2 legal in Canada?
No. TIMP2 is not an approved medicine in Canada; its classification is "Research use only; not approved". Nothing containing it is authorized for any use in people. Vials labeled "for research use only" are not exempt: that label does not make human use lawful. On the evidence, 1 human study is cited on its profile.
Can I buy TIMP2 in Canada?
No approved product exists to buy. In Canada TIMP2 is classified as "Research use only; not approved", so there is no licensed pharmacy product. Vendors selling it "for research use only" are not selling it for human use, and that label does not change its legal status. This site does not list or recommend vendors.
Is TIMP2 Health Canada approved?
No. In Canada TIMP2 is classified as "Research use only; not approved", which is not a Health Canada marketing approval. For comparison, the US FDA status is: Not approved as a therapy anywhere and never administered to a human. TIMP-2, in combination with IGFBP7, is used as a clinical laboratory biomarker for risk of acute kidney injury, which is a diagnostic use and not a treatment.. On the evidence, 1 human study is cited on its profile.
Related compounds in Canada
Full research profile
Mechanism, cited studies, FDA status and the full legal summary for TIMP2 live on its compound profile.
TIMP2 profileThis page is general information about the regulatory status of TIMP2 in Canada, current as of Sep 2026. It is not legal advice, and classifications change; check Health Canada, Health Products and Food Branch directly or consult a lawyer for a specific situation. Educational use only. This database summarizes published research. It is not medical advice and contains no dosing protocols or recommendations for personal use. The Longevity Archive has no vendor relationships and does not recommend where to buy anything.